% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • noohbs noohbs Aug 30, 2013 7:36 AM Flag

    Zalicus set to take off ! Seeking alpha on Z160


    "Zalicus Stock is starting to look very interesting at this level. Traders are no doubt waiting for the two big Phase 2 trials to offer data on potential blockbuster drug Z160 coming in late October 2013. But now might be the time value biotech investors take a look at the stock. The current market capitalization is only $65 million. That's only 4x our projected 2013 revenues of $16.0 million, and nearly one-third of the market capitalization is supported by the cash balance.

    With Z160 a potential blockbuster and the top-line supporting the stock at today's price, Zalicus could be poised for a big second half of the year."

    Sentiment: Strong Buy

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
5.65-0.26(-4.40%)Oct 13 4:00 PMEDT